Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4 Breast Neoplasms 4 Neoplasms 3 Leiomyoma 2 Vomiting 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Periampullary Carcinoma Nos 1 Pediatric Crohn's disease 1 Pain 1 Obesity 1 Nausea 1 Myasthenia Gravis 1 Motor Activity 1 Menstruation Disturbances 1 Memory Disorders 1 Hyperinsulinism 1 Hyperandrogenism 1 Hot Flashes 1 Fatigue 1 Cognitive Dysfunction 1 Cancer Pain 1 Anemia 1

Interventions

Morphine 6 nabiximols 4 Oxycodone 3 Fentanyl 3 Methadone 2 Hydromorphone 2 Acetaminophen 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 tanezumab 1 resiniferatoxin 1 naloxegol 1 Tapentadol 1 Sugars 1 Standard of Care 1 Lidocaine 1 Inosine Monophosphate 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cancer Pain × Sugars × Clear all

NCT00152854 2016-03-08

Acetaminophen for Cancer Pain

University Health Network, Toronto

Phase 3 Completed

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡